ATHA Research and Charts

ATHA - Athira Pharma Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-04-03)

Last 0.26	Change ⇓ -0.02 (0.00%)	Volume 76,071
	Open 0.26	High 0.29	Low 0.25

8EMA (Daily) 0.29	40EMA (Daily) 0.37	50EMA (Daily) 0.40	STO (Daily) 16.465	MACD Hist (Daily) -0.004
8EMA (Weekly) 0.358	40EMA (Weekly) 0.96	50EMA (Weekly) 1.16	STO (Weekly) 5.422	MACD Hist (Weekly) 0.058


Company Profile
Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.